GHDx
Published on GHDx (https://ghdx.healthdata.org)


Finland Weekly Report of the Population Serology Survey of the Corona Epidemic 2020-2021

General Info

Original or alternative title 
Koronaepidemian väestöserologiatutkimuksen viikkoraportti
Provider 
National Institute for Health and Welfare (THL) (Finland)
Tabulations only
Geography 
Finland (FIN)
Coverage type 
Country
Time period covered 
April, 2020 - December, 2022
Data type
Survey: Epi surveillance
Summary 

These reports present the main results of a serological population survey related to the corona epidemic of the Department of Health and Welfare. The study investigates the spread of the new coronavirus (SARS-CoV-2) in Finland and the extent and properties of the antibody formation (immunological resistance) caused by it. The main purpose of the study is to determine up-to-date the proportion of the population in different age groups and regions with coronavirus antibodies (so-called seroprevalence) as a sign of viral exposure, i.e. symptomatic or asymptomatic coronavirus infection. The participants of the study are selected by random sampling from different parts of Finland and a blood sample is taken in the study for the examination of antibodies. The results page is updated about every two weeks.

Keywords 
COVID-19, Disease outbreaks, Hospitals, Incidence, Medical tests

Citation

Contributors 
National Institute for Health and Welfare (THL) (Finland)
Publisher 
National Institute for Health and Welfare (THL) (Finland)
Suggested citation 
National Institute for Health and Welfare (THL) (Finland). Finland Weekly Report of the Population Serology Survey of the Corona Epidemic 2020-2021. Helsinki, Finland: National Institute for Health and Welfare (THL) (Finland).

Source URL:https://ghdx.healthdata.org/record/finland-weekly-report-population-serology-survey-corona-epidemic-2020-2021